InvestorsHub Logo
Followers 16
Posts 5825
Boards Moderated 0
Alias Born 07/16/2018

Re: scratchy post# 353553

Wednesday, 03/09/2022 8:42:01 AM

Wednesday, March 09, 2022 8:42:01 AM

Post# of 459988
THE PRESS RELEASE ON IHUB IS CORRECT, BUT WRONG ON AVXL'S ACTUAL WEBSITE!!!!!

I thought the adult Rett trial had been cha ged to a phase 3…. Press release says phase 2.

Can’t they do anything right the first time, sheesh




PR ON IHUB:

https://ih.advfn.com/stock-market/NASDAQ/anavex-life-sciences-AVXL/stock-news/87501899/anavex-life-sciences-to-participate-in-the-annual

ANAVEX®2-73 (blarcamesine), has successfully completed a Phase 2a clinical trial for Alzheimer’s disease, a Phase 2 proof-of-concept study in Parkinson’s disease dementia and both a Phase 2 and a Phase 3 study in adult patients with Rett syndrome.






PR ON AVXL'S WEBSITE:

https://www.anavex.com/post/anavex-life-sciences-to-participate-in-the-annual-needham-virtual-neuroscience-forum

ANAVEX®2-73 (blarcamesine), successfully completed a Phase 2a clinical trial for Alzheimer’s disease and recently a Phase 2 proof-of-concept study in Parkinson’s disease dementia and a Phase 2 study in adult patients with Rett syndrome.




WE GOT THIS!!!!!!!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News